Financial Incentives to Improve Medication Adherence

Depression Clinical Trial

Official title:

Financial Incentives to Improve Medication Adherence: a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04191876
• Other study ID #: 19-0739-ZHH
• Status: Completed
• Phase: N/A
• Start date: November 1, 2019
• Est. completion date: March 2, 2022

Study information

• Verified date: September 2023
• Source: Northwell Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: March 2, 2022
• Est. primary completion date: May 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Psychiatric patients with suspected or confirmed poor oral medication adherence.

2. Age 18-80 years old

3. English speaking, since the app being used is only available in English

4. Owning a Smartphone, since the app requires a Smartphone to work

5. Willing and able to participate.

Exclusion Criteria:

1. Acute anger to self or others as per investigator assessment

2. Unwilling or unable to participate

Related Conditions & MeSH terms

• Bipolar Disorder
• Depression
• Mood Disorders
• Psychotic Disorders
• Schizo Affective Disorder
• Schizophrenia

Intervention

Other:
• Wellth - Financial Incentives
Patients who are willing to participate will be offered financial incentives for medication adherence through an app (Wellth) over 10 weeks.

Locations

Country	Name	City	State
United States	The Zucker Hillside Hospital	Glen Oaks	New York

Sponsors (1)

Lead Sponsor	Collaborator
Northwell Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in medication adherence rate	Adherence rate will be measured as pills missed/pills prescribed	Between baseline and study completion (10 weeks)